Behzad Aghazadeh

Immunomedics Inc (NASDAQ:IMMU): Behzad Aghazadeh’s VenBio Select Advisor filed an amended 13D.

You can check out VenBio Select Advisor’s latest holdings and filings here.

Please follow VenBio Select Advisor (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about VenBio Select Advisor or update its stock holdings.

Behzad Aghazadeh
Behzad Aghazadeh
venBio Select Advisor

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
VENBIO SELECT ADVISOR 16,939,461 0 16,939,461 0 16,939,461 11.14%
BEHZAD AGHAZADEH 16,939,461 0 16,939,461 0 16,939,461 11.16%
Behzad Aghazadeh
Behzad Aghazadeh
venBio Select Advisor

Page 1 of 7 – SEC Filing

Washington, D.C. 20549
Under the Securities Exchange Act of 1934
(Amendment No. 4)*


(Name of Issuer)

Common Stock,
$0.01 par value per share

(Title of Class of Securities)


(CUSIP Number)
Scott Epstein
c/o venBio Select Advisor LLC
120 West 45th Street, Suite 2802
New York, NY 10036
(212) 937-4970
Eleazer Klein, Esq.
Schulte Roth & Zabel LLP
919 Third Avenue
New York, NY 10022

(212) 756-2000

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

14, 2017

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule
13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule
13d-1(f) or Rule 13d-1(g), check the following box. [ ]

(Page 1 of 7 Pages)


* The remainder of this cover page shall be filled out for a reporting
person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing
information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall
not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).

Follow Immunomedics Inc (NASDAQ:IMMU)